Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 18;14(1):e0210320.
doi: 10.1371/journal.pone.0210320. eCollection 2019.

Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study

Affiliations

Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study

Andrea Silvestrini et al. PLoS One. .

Abstract

Irisin, a recently discovered myokine, has been considered a prognostic factor in several cardiovascular diseases. Nevertheless, no data are available on the role of irisin in patients with heart failure (HF), both with preserved (HFpEF) or reduced (HFrEF) ejection fraction. We have therefore evaluated the circulating irisin levels in HFpEF and HFrEF patients, correlating them with metabolic parameters and total antioxidant capacity (TAC), as index of oxidative stress. Irisin was significantly higher in HFpEF than in HFrEF patients (7.72 ± 0.76 vs 2.77 ± 0.77 ng/ml, respectively). An inverse correlation between irisin and TAC was found in HFpEF, but not in HFrEF. Conversely, no correlation was present with HOMA index. These data support the hypothesis that a different pathophysiological mechanism is involved in the two HF subtypes, and oxidative stress modulates irisin secretion.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Irisin levels in patients with heart failure with reduced (HFrEF) and preserved (HFpEF) ejection fraction.
Left panel shows a Box-Plot comparing irisin levels in HFpEF with that in HFrEF (* p < 0.05). Right panel shows the correlation between irisin levels and TAC (in sec) in HFpEF.

References

    1. Aronis KN, Moreno M, Polyzos SA, Moreno-Navarrete JM, Ricart W, Delgado E, et al. Circulating irisin levels and coronary heart disease: Association with future acute coronary syndrome and major adverse cardiovascular events. Int J Obes. 2015;39: 156–161. 10.1038/ijo.2014.101 - DOI - PubMed
    1. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481: 463–468. 10.1038/nature10777 - DOI - PMC - PubMed
    1. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61: 1725–1738. 10.1016/j.metabol.2012.09.002 - DOI - PMC - PubMed
    1. Gouni-Berthold I, Berthold HK, Huh JY, Berman R, Spenrath N, Krone W, et al. Effects of Lipid-Lowering Drugs on Irisin in Human Subjects In Vivo and in Human Skeletal Muscle Cells Ex Vivo. Luque RM, editor. PLoS One. 2013;8: e72858 10.1371/journal.pone.0072858 - DOI - PMC - PubMed
    1. Aydin S, Kuloglu T, Aydin S, Eren MN, Celik A, Yilmaz M, et al. Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: Cardiac muscle produces more irisin than skeletal muscle. Peptides. 2014;52: 68–73. 10.1016/j.peptides.2013.11.024 - DOI - PubMed